Preparing a registration dossier for drugs in Japan typically takes 12 to 18 months. This timeframe includes compiling necessary data, conducting clinical trials, and meeting regulatory requirements set by the Pharmaceuticals and Medical Devices Agency (PMDA). The process duration can vary based on drug complexity and specific regulatory demands.